Skip to content

Addiction: all studies

Page 39 of 855: studies 381 to 390 of 8,547, newest first. Back to the addiction overview

Research

Associations between classic psychedelics and nicotine dependence in a nationally representative sample

Scientific Reports June 22, 2022 Grant Jones, Joshua Lipson, Matthew K. Nock 31 citations

Abstract Tobacco use is the single largest cause of preventable death worldwide, but none of the established treatments aimed at smoking cessation work for a majority of smokers. As such, there is an urgent need for interventions capable of reliably treating nicotine addiction. The use of classic psychedelics has been associated with lower odds of many forms of substance dependence. Here we...

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

Addiction Neuroscience June 22, 2022 Fúlvio Rieli Mendes, Cristiane Dos Santos Costa, Victor Distefano Wiltenburg et al. 55 citations

Substance use disorder (SUD) is a global public health concern that affects millions of people worldwide. Considering current research, addiction has been noted as the last stage of a chronic disease that may impair brain reward circuit responses and affects personal and social life. Treatments for SUD face challenges including availability and limited pharmacological response, often resulting...

Traditional Amazonian medicine in addiction treatment: Qualitative results

SSM: Qualitative Research in Health June 4, 2022 David M. O’shaughnessy, Zoltán Sarnyai, Frances Quirk et al.

Traditional Amazonian medicine, and in particular the psychoactive substance ayahuasca, has generated significant research interest along with the recent revival of psychedelic medicine. Previously we published within-treatment quantitative results from a residential addiction treatment centre that predominately employs Peruvian traditional Amazonian medicine, and here we follow up that work...

Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.

European Archives of Psychiatry and Clinical Neuroscience June 1, 2022 Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha et al. 48 citations

Ayahuasca is a hallucinogenic/psychedelic traditionally used for ritual and therapeutic purposes. One such therapeutic use is related to Substance Use Disorders (SUDs). A previous systematic review of preclinical and human studies published until 2016 suggested that ayahuasca and its alkaloids have therapeutic effects in the treatment of SUDs. To conduct an update of this previous review. A...

Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay

Journal of Psychoactive Drugs May 4, 2022 Ismael Apud, Juan Scuro, Ignacio Carrera et al. 14 citations

The current article presents a mixed qualitative-quantitative observational study of the effect of ayahuasca ritual on subjective experiences and personality traits on participants of a center specialized in the treatment of substance use disorder in Uruguay. When comparing the psychological traits of ayahuasca participants to a control group, quantitative results using the...

The Effectiveness of Mindfulness-based Cognitive Therapy on the Level of Anxiety and Quality of Life in Women with Opioid Use Disorder

فصلنامه علمی و پژوهشی اعتیادپژوهی May 1, 2022 Paria Shakibayi, Parinaz Ghayuomi

‫ذهن‬ ‫بر‬ ‫مبتني‬ ‫درماني‬ ‫شناخت‬ ‫اثربخشي‬ ‫کيفيت‬ ‫و‬ ‫اضطراب‬ ‫سطح‬ ‫بر‬ ‫آگاهي‬ ‫افيوني‬ ‫مواد‬ ‫مصرف‬ ‫اختالل‬ ‫با‬ ‫زنان‬ ‫زندگي‬

ALTERED STATES OF CONSCIOUSNESS IN GAMBLING AND INTERNET GAMING DISORDERS AS A RISK FACTOR FOR ADDICTION

Psychological Applications and Trends April 22, 2022 Tetiana Zinchenko, Edward Shatochin

"In GD and IGD, both at the preclinical level of problem game and at the clinical level of pathological game, altered states of consciousness are observed during the game and shortly before. In the scientific literature, they are called flow-state, dark flow, game trance, game intoxication, and so on. During these states, the person loses touch with reality, the real life situation completely...

Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample

Scientific Reports April 7, 2022 Grant Jones, Jocelyn A. Ricard, Joshua Lipson et al. 56 citations

Abstract Opioid use disorder (OUD) is a major source of morbidity and mortality in the U.S. and there is a pressing need to identify additional treatments for the disorder. Classic psychedelics (psilocybin, peyote, mescaline, LSD) have been linked to the alleviation of various substance use disorders and may hold promise as potential treatments for OUD. The aim of this study was to assess...

Addictions: current perspectives.

Journal of Analytical Psychology April 1, 2022 Maria Paula De Magalhães Tavares de Oliveira

This paper seeks to integrate the perspectives of analytical psychology and neurobiology in order to understand the phenomenon of addiction in contemporary society, taking into account the COVID-19 pandemic. Jung emphasizes the role of the psyche's self-regulation and the development of consciousness in the individuation process. The search for experiences of transcendence is archetypal and can...

DOI: 10.1111/1468-5922.12787 (opens in new tab) Full text (opens in new tab) Analytische psychologie Covid-19 pandemic Covid-19-pandemie Covid-19大流行 +38

Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder

March 25, 2022

Ketamine plus mindfulness psychotherapy was more effective for sustained abstinence from alcohol than placebo plus alcohol psychoeducation. Other combinations of these therapies were not significantly different from one another in this small pilot trial (N=20-25 in each group). Adverse effects were minimal, suggesting that current alcohol use is not a contraindication for consideration of...